Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP616699.RADk2UjQE5ZlC8mL0NIhorgMtCEESGF-mof9kVxw2ekbM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP616699.RADk2UjQE5ZlC8mL0NIhorgMtCEESGF-mof9kVxw2ekbM130_assertion type Assertion NP616699.RADk2UjQE5ZlC8mL0NIhorgMtCEESGF-mof9kVxw2ekbM130_head.
- NP616699.RADk2UjQE5ZlC8mL0NIhorgMtCEESGF-mof9kVxw2ekbM130_assertion description "[Endocrine biochemistry at presentation showed hypogonadotropic hypogonadism (LH 2.4 U/L, FSH <1.0 IU/L, testosterone 2.8 nmol/L) with increased serum estrone (E(1), 821 pmol/L) and estradiol (E(2), 797 pmol/L) and subclinical ACTH-independent hypercortisolism (serum cortisol post 1mg overnight dexamethasone suppression test, 291 nmol/L).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616699.RADk2UjQE5ZlC8mL0NIhorgMtCEESGF-mof9kVxw2ekbM130_provenance.
- NP616699.RADk2UjQE5ZlC8mL0NIhorgMtCEESGF-mof9kVxw2ekbM130_assertion evidence source_evidence_literature NP616699.RADk2UjQE5ZlC8mL0NIhorgMtCEESGF-mof9kVxw2ekbM130_provenance.
- NP616699.RADk2UjQE5ZlC8mL0NIhorgMtCEESGF-mof9kVxw2ekbM130_assertion SIO_000772 20467160 NP616699.RADk2UjQE5ZlC8mL0NIhorgMtCEESGF-mof9kVxw2ekbM130_provenance.
- NP616699.RADk2UjQE5ZlC8mL0NIhorgMtCEESGF-mof9kVxw2ekbM130_assertion wasDerivedFrom befree-20140225 NP616699.RADk2UjQE5ZlC8mL0NIhorgMtCEESGF-mof9kVxw2ekbM130_provenance.
- NP616699.RADk2UjQE5ZlC8mL0NIhorgMtCEESGF-mof9kVxw2ekbM130_assertion wasGeneratedBy ECO_0000203 NP616699.RADk2UjQE5ZlC8mL0NIhorgMtCEESGF-mof9kVxw2ekbM130_provenance.